Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Jan 17, 2020 07:30 ET
MCTC Files 6th Hemp Extract Delivery Patent - CBD Coffee Pods and Associated Delivery System
via NetworkWire -- MCTC Holdings, Inc. (OTC: MCTC), a cannabinoid science forward company developing unique infusion technologies and cannabinoid delivery systems, today announced the filing of a patent for single-serving coffee pods containing...
Jan 17, 2020 07:30 ET
NexTech Presenting at The AlphaNorth Capital Conference on January 18th
NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the leader in augmented reality (AR) for eCommerce and AR learning applications is pleased to announce that NexTech CEO Evan Gappelberg will be presenting at AlphaNorth Capital...
Jan 17, 2020 07:17 ET
MacDonald Mines Drills Wide Breccia Zone Outside of the Historic Scadding Deposit Including 0.4g/t Gold and 0.01% Cobalt
MacDonald Mines Exploration Ltd. (TSX-V: BMK) (“MacDonald Mines”, “MacDonald” or the “Company”) announces results from two diamond drill holes completed last fall at its SJP property, 40 kilometres east of Sudbury, Ontario.  Both drill holes...
Jan 17, 2020 07:00 ET
Emerald Health Therapeutics’ Joint Venture Partner Withdraws Purported $5.94 Million Investment in Pure Sunfarms
Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that Village Farms International, Inc. ("Village Farms") has withdrawn its attempt to make an unsupported  additional equity contribution in their joint...
Jan 17, 2020 07:00 ET
Emerging Markets Report:  A Very Big Deal
It doesn’t take an analyst to suggest that high value merger and acquisition activity in any industry is a bullish sign. And it assuredly doesn’t take any research firm at all to suggest that an eczema related company like Hoth Therapeutics, Inc....
Jan 17, 2020 07:00 ET
Philips partners with the United Nations Population Fund and the Government of Republic of the Congo to reduce maternal and newborn mortality
January 17, 2020 A comprehensive ‘Emergency obstetric and newborn care’ (EmONC) program will be implemented in healthcare facilities in underserved communities in the Republic of the Congo  The agreement is a tangible local milestone of the...
Jan 17, 2020 06:45 ET
Brown & Brown, Inc. Announces the Asset Acquisition of Texas All Risk
J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. (NYSE:BRO); and Kelly A. Davis, the owner of All Risk General Agency, Inc.; Select General Agency, LLC; TARGA Investment Corporation; TARGA Premium Finance Company, Inc.; and Texas...
Jan 17, 2020 06:45 ET
CrossAmerica Partners to Announce Year-End/Fourth Quarter 2019 Earnings Results on February 25
CrossAmerica Partners to Announce Year-End/Fourth Quarter 2019 Earnings Results on February 25 ALLENTOWN, PA, January 17, 2020 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its year-end/fourth quarter 2019 results...
Jan 17, 2020 06:45 ET
Golden Minerals Reports Promising Bio-Oxidation Test Results
Golden Minerals Company (NYSE American and TSX: AUMN) (“Golden Minerals”, “Golden” or “the Company”) is pleased to announce it has received promising results from metallurgical test work conducted on pyrite-arsenopyrite flotation concentrates from...
Jan 17, 2020 06:45 ET
Wabash National Corporation Announces Leadership Changes
Wabash National Corporation (NYSE: WNC), a leading producer of engineered solutions for the transportation, logistics and distribution industries, today announced the appointment of Mike Pettit as Senior Vice President and Chief Financial Officer....
Jan 17, 2020 06:30 ET
First Horizon Releases 2019 Fourth Quarter and Full Year Financial Results
First Horizon National Corp. (NYSE:FHN) today announced its 2019 fourth quarter and full year financial results. The company ended a year of high returns and strong growth by announcing a merger of equals agreement with IBERIABANK Corporation and...
Jan 17, 2020 06:30 ET
Radisson continues to intersect high-grade gold at depth and within the current resource area at O’Brien
Radisson Mining Resources Inc. (TSX-V: RDS, OTC: RMRDF): (“Radisson” or the “Company") today announced significant high-grade Gold intercepts from the 20,000 m exploration drill program underway at its O’Brien gold project located along the...
Jan 17, 2020 06:15 ET
Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors
Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and...
Jan 17, 2020 06:00 ET
Algernon Pharmaceuticals Appoints Novotech as CRO for First Phase 2 Trial and Announces Novotech’s $220K Equity Investment
Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, is pleased to announce that it has appointed Novotech as the contract research organization...
Jan 17, 2020 06:00 ET
mCig, Inc. Consumer Division (BareRoots) Receives Purchase Order for 10,000 Monthly Boxes of the Company’s Proprietary CBD-Based Products
via NEWMEDIAWIRE -- mCig, Inc. (OTCQB:MCIG), vertically integrated company focused on the development and commercialization of over the counter, science-driven, botanical nutrigenetics that target the endocannabinoid system, today announced that...
Jan 17, 2020 06:00 ET
Osisko Metals Delivers Milestone Year and Outlines Objectives for H1 2020
Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce a summary of 2019 highlights and a H1 2020 corporate plan and exploration outlook. Jeff Hussey, President and CEO,...
Jan 17, 2020 05:00 ET
LIZHI INC. Announces Pricing of Initial Public Offering
LIZHI INC. (“LIZHI” or the “Company”) (NASDAQ: LIZI), a leading online UGC audio community and interactive audio entertainment platform in China, today announced that it has priced its initial public offering of 4,100,000 American depositary shares...
Jan 17, 2020 04:01 ET
2020 FCA Corporate Calendar
2020 Corporate Calendar Fiat Chrysler Automobiles N.V. (NYSE: FCAU / MTA: FCA) announced today the following corporate calendar for year 20201: Earnings Releases6 February 2020 - Group Results for Fourth Quarter and Full Year 20195 May 2020 -...
Jan 17, 2020 01:46 ET
FCA Confirms Discussions with Foxconn
FCA Confirms Discussions with Foxconn Fiat Chrysler Automobiles N.V. (MTA: FCA / NYSE: FCAU, “FCA”) confirmed today that it is in discussions with Hon Hai Precision Ind. Co., Ltd. (Foxconn) regarding the potential creation of an equal joint venture...
Jan 17, 2020 00:36 ET
I-MAB Announces Pricing of U.S. Initial Public Offering
I-Mab (“I-Mab” or the “Company”) (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical...